Medicine is experiencing an unprecedented focus on quantifying and improving healthcare quality. The American College of Cardiology (ACC) and the American Heart Association (AHA) have developed a multifaceted strategy to facilitate the process of improving clinical care. The initial phase of this effort was to create clinical practice guidelines that carefully review and synthesize available evidence to better guide patient care. Such guidelines are written in a spirit of suggesting diagnostic or therapeutic interventions for patients in most circumstances. Accordingly, significant judgment by clinicians is required to adapt these guidelines for the care of individual patients, and these guidelines can be generated with varying degrees of confidence on the basis of available evidence.
measures when appropriate (see Appendixes A and B).
All the measures contained in this set have limitations and challenges to implementation that could result in unintended consequences when used for accountability purposes. The implementation of these measures for purposes other than QI require field testing to address issues related to, but not limited to, sample size, reasonable frequency of use for an intervention, comparability, and audit requirements. The way in which these issues are addressed would be highly dependent on the type of accountability system developed, including data collection method, assignment of patients to physicians for measurement purposes, baseline measure setting, incentive system, and public reporting method among others. The ACC/AHA encourages those interested in working on implementation of these measures for purposes beyond QI to work with the ACC/AHA to understand these complex issues in pilot testing projects that can measure the impact of any limitations and provide guidance on possible refinements of the measures that would make them more suitable for additional purposes.
In the process of facilitating the measurement of cardiovascular healthcare quality, the ACC/AHA Performance Measurement Sets can serve as a vehicle for more rapidly translating the strongest clinical evidence into practice. These documents are intended to provide practitioners with "tools" for measuring the quality of care and for identifying opportunities to improve. Because the target audience and unit of analysis for these measures is the practitioner, they were constructed from the provider's perspective and were not intended to characterize "good" or "bad" practice but to be part of a system with which to assess and improve healthcare quality. It is our hope that an application of these performance measures within a system of QI will provide a mechanism through which the quality of medical care can be measured and improved.
-Robert O. Bonow, MD, FACC, FAHA, FACP, Chair, ACCF/AHA Task Force on Performance Measures
Over the past 4 decades, cardiac rehabilitation/ secondary prevention (CR) services have become recognized as a significant component in the continuum of care for persons with cardiovascular disease (CVD). The role of CR services in the comprehensive secondary prevention of CVD events is well documented [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] and has been promoted by various healthcare organizations and position statements. 4, [12] [13] [14] [15] [16] [17] [18] However, performance measures for CR services have not been published to date.
To formalize performance measures for CR services, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)/American College of Cardiology (ACC)/American Heart Association (AHA) Cardiac Rehabilitation/Secondary Prevention Performance
The role of performance measurement writing committees is not to perform a primary evaluation of the medical literature; this is undertaken by ACC/AHA guidelines committees. However, performance measurement writing committees work collaboratively with guidelines committees so that the guideline recommendations are written with a degree of specificity that supports performance measurement and so that new knowledge can be rapidly incorporated into performance measurement. Development of the ACC/AHA guidelines includes a detailed review of and ranking of the evidence available for the diagnosis and treatment of specific disease areas. Published guideline recommendations employ the ACC/AHA classification systems I, IIa, IIb, and III (Table 1) .
So as not to duplicate performance measure development efforts, writing committees were also instructed to evaluate existing nationally recognized performance measures using the ACC/AHA "attributes of good performance measures." The measure specifications were adopted for those performance measures that meet these criteria. Such measures have established validity, reliability, and feasibility and would form the foundation of the ACC/AHA measurement sets. Furthermore, writing committees are encouraged to identify additional performance measures that correspond to those key areas of quality proven to improve patient outcomes.
The ACC/AHA Performance Measurement Sets are to be applied in the inpatient and/or outpatient setting depending upon the topic. Although inpatient measures have traditionally been captured by retrospective data collection, the increased use of electronic medical records allows for prospective collection in the inpatient and outpatient settings. Prospective data collection is itself a continuous QI process. The performance measures quantify explicit actions performed in carefully specified patients for whom adherence should be advocated in all but the most unusual circumstances. In addition, the measures are constructed with the intent to facilitate both retrospective and prospective data collection using explicit administrative and/or easily documented clinical criteria. Furthermore, the data elements required to construct the performance measures are identified and linked to existing ACC/AHA Clinical Data Standards to encourage the standardization of cardiovascular measurement.
Although the focus of the performance measures writing committees is to develop measures for internal QI, it is appreciated that other organizations may use these measures for external reporting of provider performance. Therefore, it is within the scope of the writing committee's task to comment on the strengths and limitations of externally reporting potential performance measures. Specifically, this was done in the "Challenges to implementation" sections in each of the performance www.jcrjournal.com Clearly, there is a need and also a prime opportunity to reduce the gap in delivery of CR services to persons with CVD. Such an improvement in CR delivery will require better approaches in the referral to, enrollment in, and completion of programs in CR. It is anticipated that the implementation of CR performance measure sets will stimulate changes in the clinical practice of preventive and rehabilitative care for persons with CVD.
Writing Committee Structure and Members
To formalize performance measures for CR services, the AACVPR/ACC/AHA Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee was convened in November 2005. The writing committee was composed of nominated representatives from the AACVPR, the ACC, and the AHA, including past and current representatives of the ACC Task Force on Performance Measures, past and current presidents of the AACVPR, and clinicians with expertise in general clinical cardiology, heart failure, CVD, and CR. An initial committee meeting was held in Kansas City, Missouri, on January 23 and 24, 2006. Committee meetings were otherwise held by teleconference, generally at weekly intervals.
Relationships With Industry
Committee members volunteered their time to participate in the writing committee and acknowledged any Measures Writing Committee was convened in November 2005. The writing committee was given the charge of developing performance measures that cover 2 specific aspects of CR services: (1) referral of eligible patients to a CR program; and (2) delivery of CR services through multidisciplinary CR programs.
The ultimate purpose of these performance measure sets is to help improve the delivery of CR to reduce cardiovascular mortality and morbidity and optimize health in persons with CVD, including acute myocardial infarction (MI) or status post coronary artery bypass graft (CABG) surgery, percutaneous coronary intervention (PCI), stable angina, and heart transplantation or heart valve surgery. Using the previously published methodology of the ACC and the AHA, 1, 19 performance measures for the referral of eligible patients to a CR program and the delivery of CR services through multidisciplinary CR programs were developed, focusing on processes of care that have been documented to help improve patient outcomes (using the ACC/AHA system for classification of recommendations and level of evidence for guidelines and clinical recommendations shown in Table 1 ). Both inpatient and outpatient settings of cardiovascular care were considered, resulting in performance measures being created for 3 specific settings: (1) hospitals; (2) office practices; and (3) CR programs.
Rationale for CR Performance Measures/ Secondary Prevention
The rationale for developing and implementing performance measure sets for referral to and delivery of CR services is based on several key factors:
❏ There has been growing scientific evidence over the past 3 decades on the benefits of CR services for persons with CVD. 2, 17, 20 Evidence suggests that the benefits of CR services are as significant in recent years as they were in the prethrombolytic era. 9, 21 Because of this mounting evidence, a number of healthcare organizations have endorsed the use of CR services in persons with CVD by including provisions for CR in their practice guidelines and practice management position papers. 4, 12, 13, 18, [21] [22] [23] ❏ Despite both the known benefits of CR and the widespread endorsement of its use, CR is vastly underutilized, with less than 30% of eligible patients participating in a CR program after a CVD event. [24] [25] [26] Reasons for this gap in CR participation are numerous, but the most critical and potentially most correctable reasons revolve around obstacles in the initial referral of patients to CR programs. These obstacles can be reduced through the systematic adoption of standing orders and other similar tools for CR referral for appropriate hospitalized patients. 27 Furthermore, 
Review and Endorsement
A public comment period was held for this document from December 11, 2006 , until January 11, 2007 . Reviewers were asked to provide comments on the document on the basis of the rating form and guide shown in Appendix D. Reviewer comments were considered and incorporated into a revised version of the document. Review and final approval of the final version of the paper was obtained through the governing bodies from the AACVPR, the ACC, and the AHA. Endorsement of the final paper was sought from key partnering organizations. 30 This definition reinforced the observation that CR is an integral component in the overall management of patients with CVD, that the patient plays a significant role in the successful outcome of CR, and that CR is an important source of services aimed at the secondary prevention of CVD events. 2, 4, 12 Building on this original definition, a number of other complementary definitions of CR have been promulgated by various organizations including the US Public Health Service, the AHA, the AACVPR, and the Canadian Association of Cardiac Rehabilitation. 4, 18 These updated definitions emphasize the integral role of CR in the secondary prevention of CVD.
METHODOLOGY

Definition of CR
The definition used by the US Public Health Service and by the Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee is as follows:
Cardiac rehabilitation services are comprehensive, long-term programs involving medical evaluation, prescribed exercise, cardiac risk factor modification, education, and counselling. These programs are designed to limit the physiologic and psychological effects of cardiac illness, reduce the risk for sudden death or re-infarction, control cardiac symptoms, stabilize or reverse the atherosclerotic process, and enhance the psychosocial and vocational status of selected patients. 4 CR programs are generally divided into 3 main phases:
1. Inpatient CR (also known as phase I CR): A program that delivers preventive and rehabilitative services to hospitalized patients following an index CVD event, such as an MI/acute coronary syndrome.
Early outpatient CR (also known as phase II CR):
A program that delivers preventive and rehabilitative services to patients in the outpatient setting early after a CVD event, generally within the first 3 to 6 months after the event but continuing for as much as 1 year after the event.
Long-term outpatient CR (also known as phase III or phase IV CR):
A program that provides longer-term delivery of preventive and rehabilitative services for patients in the outpatient setting.
The main focus of this position paper is on the referral to and delivery of early outpatient CR services principally because it is the component of CR that has been most widely documented to help reduce the risk of CVD mortality among its participants. The thrust of this document is focused on the management of persons with coronary artery disease-related conditions (noted in the list above with an asterisk), but CR services are considered appropriate and beneficial for persons (1) after heart valve surgical repair or replacement and (2) after heart or heart/lung transplantation (as previously listed). [31] [32] [33] [34] Furthermore, growing evidence from published studies supports a CR benefit for persons with chronic heart failure or peripheral arterial disease. 35, 36 However, formal recommendations by healthcare organizations to approve and/or cover CR services in these patient populations will depend upon policy decision makers and, particularly, in the case of chronic heart failure, the results of ongoing research studies. the CR program settings. Staff members within each of these areas who help provide care to persons with CVD are held accountable for the various aspects of CR services (referral to, enrollment in, and delivery of CR services).
Definition of Appropriate Patients for CR
Literature Review and Evidence Base
There is substantial evidence to conclude that CR is reasonable and necessary following MI, CABG surgery, stable angina, heart valve repair or replacement, PCI, and heart or heart/lung transplantion. 12 Outpatient, medically supervised CR, as described by the US Public Health Service, is a comprehensive, long-term intervention including medical evaluation, prescribed exercise, cardiac risk-factor modification, education, and counseling typically initiated 1 to 3 weeks after hospital discharge and typically including electrocardiographic monitoring of patients (see "Definition of CR" section). 4 Meta-analyses and systematic reviews 2,3,5-11 provide and summarize the extensive evidence that has been generated from published randomized clinical trials demonstrating that exercise-based CR services are beneficial for patients with established CVD. These benefits include improved processes of care and risk-factor profiles that are closely linked to subsequent mortality and morbidity. Pooled data from randomized clinical trials of CR demonstrate a mortality benefit of approximately 20% to 25% 2,3,5-11 and a trend toward reduction in nonfatal recurrent MI over a median follow-up of 12 months.
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Definition and Selection of Measures
The Cardiac Rehabilitation/Secondary Prevention Performance Measure Writing Committee initially identified 39 factors from various practice guidelines and other reports that were considered potential performance measures for the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets (see Table 1 for standard guidelines that were used to rate the classification of recommendations and level of evidence for assessing these factors). The group evaluated these factors according to guidelines established by the ACC/AHA Task Force on Performance Measures. 1 Those measures that were deemed to be most evidence-based, interpretable, actionable, clinically meaningful, valid, reliable, and feasible were included in the final performance measurement sets. Once these measures were identified, the writing committee then discussed and refined, over a series of months, the definition, content, and other details of each of the selected measures.
While most performance measures are designed for a specific condition and phase of a particular disease, CR referral is applicable and appropriate for a number of different conditions and phases of CVD. Accordingly, the writing committee created 2 sets of performance Persons who are potentially eligible for CR may, in fact, have barriers that limit their participation in CR. Such barriers include those that are patient-oriented (eg, patient refusal), others that are provider-oriented (eg, provider deems the patient ineligible for CR due to a high-risk medical condition and/or an absolute contraindication to exercise), and still others that are related to the healthcare system and/or societal barriers (eg, lack of a CR program, lack of insurance coverage). 17 Patients with such barriers may be excluded from the number of patients who are considered to be eligible for CR referral (Appendix A, under the "Numerator" criteria for assessing the percentage of eligible patients who have been referred to a CR program). It should be noted, however, that even though some persons may have significant patient-or provider-oriented barriers to CR referral, nearly all patients with CVD could benefit from at least some components of a comprehensive, secondary prevention CR program.
Overview of Performance Measures Created
Both structure-and process-based performance measures are included in the Cardiac Rehabilitation/ Secondary Prevention Performance Measurement Sets. While important and related, specific measures focused on clinical outcomes are not included. The performance measures that are included are designed to help healthcare groups identify potentially correctable and actionable "upstream" sources of suboptimal clinical care, such as structure-and process-based gaps in CR services. Details for the dimensions of care included in the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets are outlined as follows:
1.
Structure-based measures quantify the infrastructure from which CR is provided and are based on the provision of appropriate personnel and equipment to satisfy high-quality standards of care for CR services. For example, a structure-based performance measure for a CR program is one that specifies that a CR program has appropriate personnel and equipment to provide rapid care in medical emergencies that may occur during CR program sessions.
2.
Process-based measures quantify specific aspects of care and are designed to capture all relevant dimensions of CR care. For example, a process-based performance measure for a CR program is one that specifies that all patients in a CR program undergo comprehensive, standardized assessment of their cardiovascular risk factors upon entry to the CR program.
It should also be noted that the Cardiac Rehabilitation/ Secondary Prevention Performance Measurement Sets have been designed for 3 different geographical settings of care: (1) the hospital; (2) the physician office; and (3) www.jcrjournal.com AACVPR/ACC/AHA 2007 Performance Measures / 265 www.jcrjournal.com include hospitals and healthcare systems as well as physician practices and other healthcare settings with primary responsibility for the care of patients after a CVD event.
Brief Summary of the Measures
The Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set A (Appendix A) is based on 2 criteria for the appropriate referral of patients to an early outpatient CR program:
1. all hospitalized patients with a qualifying CVD event are referred to an early outpatient CR program prior to hospital discharge; and 2. all outpatients with a qualifying diagnosis within the past year who have not already participated in an early outpatient CR program are referred to an early outpatient CR program by their healthcare provider.
It should be noted that the healthcare system and its providers who care for patients during and/or after CVD events are accountable for these performance measures. Physicians or other healthcare providers who see patients with CVD but who do not have a primary role in managing their CVD are not accountable for meeting these criteria. For example, an ophthalmologist who is performing an annual retinal examination on a diabetic patient in the year after his or her MI would not be responsible for referring the patient to a CR program. Additional details regarding this performance measurement set are included in Appendix A.
measures, one related to the appropriate referral of patients to a CR program and another set related to optimal performance of a CR program itself. In creating the first set, the writing committee sought to create a measure that would be appropriate for insertion into other performance measurement sets for which CR referral would be appropriate (eg, performance measurement sets for care of patients following MI, PCI, or CABG surgery). Figure 1 outlines the overall organization of these 2 types of measures and their intended applications.
MEASURES RELATED TO EARLY OUTPATIENT CR REFERRAL
The performance measures that are related to the referral of appropriate patients to an early outpatient CR program are described in the next section.
Populations, Care Period, and Responsible Parties
Patients who are appropriate for referral to an early outpatient CR program include those patients who, in the previous 12 months, have had any of the diagnoses listed in the "Definition of appropriate patients for CR" section. The CR services are generally most beneficial when delivered soon after the index hospitalization. However, there are often clinical, social, and logistical reasons that delay enrollment in CR. For this reason, many third-party payers allow CR services to begin up to 6 to 12 months following a cardiac event. Because patients can be referred to CR at varying times following a CVD event, parties responsible for the referral of patients to CR referral tool for outpatient practice settings. Figure 4 shows an example of a performance measure tracking tool that can be used by healthcare systems following an MI, with the performance measure of CR referral included in the performance measurement tool. These tools are given as examples and not as endorsed instruments. Healthcare systems and providers are encouraged to develop and implement systematic tools that are most appropriate and most
Data Collection Instruments
Examples of tools that may be of help in applying the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set A (Appendix A) into practice are included in Figures 2 and 3 . Figure 2 shows an example of a standardized CR referral tool that healthcare systems could potentially use in the inpatient setting, whereas Figure 3 shows an example of a potential CR designed to be included in (ie, "plugged into") other related performance measurement sets for which referral to a CR program would be considered an appropriate component of high-quality care (eg, can be "plugged into" the performance measurement set for management of patients with MI).
effective for their particular setting and patient population groups.
Inclusion in Other Performance Measurement Sets
The Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set A (Appendix A) is 
Data Collection Instruments
The Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set B is intended to be used prospectively to review a program's internal procedures with the ultimate goal of enhancing the QI process. To aid in data compilation, ideally collected prospectively, a data collection tool or flow sheet is recommended. An example of such a collection tool is shown in Table 2 . Healthcare systems and practices are encouraged to develop and/or use a tool that conforms to local practice patterns and standards.
DISCUSSION
The aim of the Cardiac Rehabilitation/Secondary Prevention Performance Measures Writing Committee was to address 2 important, persistent gaps in the quality of care for patients with CVD: namely, inadequate referral rates to CR programs and the need for minimum performance standards for such CR programs. Currently, a minority of patients receives CR services and secondary prevention services due, in general, to a number of patient-, provider-, and healthcare system-related barriers. The writing committee designed performance measurement sets that hold healthcare providers, CR program staff members, and leaders of healthcare systems accountable for the ultimate goal of linking eligible patients to the appropriate CR services following a qualifying CVD event.
The writing committee focused its attention on 2 general performance measurement sets: (1) referral of eligible patients to an outpatient CR program; and (2) delivery of appropriate CR services by CR programs. The first performance measure is designed to be used as a plug-in component to other performance measurement sets for which CR referral is deemed appropriate (eg, post-MI,
MEASURES TO DEFINE QUALITY EARLY OUTPATIENT CR PROGRAMS
The second set of performance measures included in the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets-Performance Measurement Set B (Appendix B)-relates to the optimal structure and processes of care for CR programs themselves and is described in the next section.
Populations, Care Period, and Responsible Parties
Patients who are appropriate for entry into a CR program include persons 18 years or older who, during the previous year, have had 1 or more of the qualifying diagnoses listed in the "Definition of appropriate patients for CR" section. Patients who are considered ineligible for CR services, by patient-oriented or provider-oriented criteria (see the "Definition of appropriate patients for CR" section), may still be appropriate candidates for enrollment in modified CR programs that adapt their services to a given patient's limitations, geographic or otherwise. The period of care for early outpatient CR typically begins 1 to 3 weeks after the index CVD event and lasts up to 3 to 6 months.
The unit of analysis for the Cardiac Rehabilitation/ Secondary Prevention Performance Measurement Set B is the healthcare system's CR program(s). Therefore, the responsible parties for the performance of early outpatient CR services include members of the CR program staff-the medical director, nurses, exercise specialists, cardiovascular administrators, and other members of the CR team.
Brief Summary of the Outpatient CR Program Measurement Set
The Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set B for the delivery of CR services includes those measures that were considered by the writing committee to have the highest level of evidence and consensus support among its members.
The measures selected include both structure-and process-based measures that are used to assess the following policies and procedures by CR programs: (continues)
T a b l e 2 • (Continued)
ing those patients who have undergone heart valve surgery or who have received heart or heart/lung transplantation, are also appropriate for CR referral. In addition, there is growing evidence for the benefits of CR in persons with other cardiovascular conditions, including heart failure and peripheral vascular disease. As more evidence becomes available for the benefits of CR in these patient groups, they would be included in future iterations of the Cardiac Rehabilitation/Secondary Prevention Performance Measurement Sets.
To be effective, the recommendations of the writing committee would need to be adapted, adopted, and post-CABG surgery, post-PCI). The second performance measurement set is designed to clarify structure-and process-based performance measures that serve as a standard for CR programs, as they work to continually improve the quality of care provided to their patients with CVD and thereby optimize their patients' healthrelated outcomes.
The writing committee did not include performance measures for all patient groups that may benefit from CR services, but focused on those groups of patients with the most current scientific evidence and other supporting evidence for benefits from CR. Other patient groups, includ-sessions or may include other options such as homebased approaches. If alternative CR approaches are used, they should be designed to meet appropriate safety standards).
A referral is defined as an official communication between the healthcare provider and the patient to recommend and carry out a referral order to an early outpatient CR program. This includes the provision of all necessary information to the patient that will allow the patient to enroll in an early outpatient CR program. This also includes a communication between the healthcare provider or healthcare system and the CR program that includes the patient's referral information for the program. A hospital discharge summary or office note may potentially be formatted to include the necessary patient information to communicate to the CR program [the patient's cardiovascular history, testing, and treatments, for instance]. All communications must maintain appropriate confidentiality as outlined by the 1996 Health Insurance Portability and Accountability Act [HIPAA].)
Exclusion Criteria:
❏ Patient-oriented barriers (patient refusal, for example) ❏ Provider-oriented criteria (patient deemed to have a high-risk condition or a contraindication to exercise, for example) ❏ Healthcare system barriers (financial barriers or lack of CR programs near a patient's home, for example)
Denominator: Number of hospitalized patients in the reporting period hospitalized with a qualifying event/diagnosis who do not meet any of the exclusion criteria mentioned above.
Period of Assessment: Inpatient hospitalization.
Method of Reporting: Proportion of healthcare system's patients with a qualifying event/diagnosis who had documentation of their referral to an outpatient CR program.
Sources of Data:
Administrative data and/or medical records.
Rationale
A key component to outpatient CR program utilization is the appropriate and timely referral of patients. Generally, the most important time for this referral to take place is while the patient is hospitalized for a qualifying event/ diagnosis (MI, CSA, CABG, PCI, cardiac valve surgery, or cardiac transplantation).
This performance measure has been developed to help healthcare systems implement effective steps in their systems of care that will optimize the appropriate referral of a patient to an outpatient CR program.
This measure is designed to serve as a stand-alone measure or, preferably, to be included within other implemented by healthcare systems, healthcare providers, health insurance carriers, chronic disease management organizations, and other groups in the healthcare field that have responsibility for the delivery of care to persons with CVD. Such strategies should be part of an overall systemsbased approach to minimize inappropriate gaps and variation in patient care, optimize delivery of health-promoting services, and improve patient-centered health outcomes.
-Acknowledgments- All patients hospitalized with a primary diagnosis of an acute myocardial infarction (MI) or chronic stable angina (CSA), or who during hospitalization have undergone coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation are to be referred to an early outpatient cardiac rehabilitation/ secondary prevention (CR) program.
Numerator: Number of eligible patients with a qualifying event/diagnosis who have been referred to an outpatient CR program prior to hospital discharge or have a documented medical or patient-centered reason why such a referral was not made.
(Note: The program may include a traditional CR program based on face-to-face interactions and training www.jcrjournal.com
Challenges to Implementation
Identification of all eligible patients in an inpatient setting will require that a timely, accurate, and effective system be in place. Communication of referral information by the inpatient hospital service team to the outpatient CR program represents a potential challenge to the implementation of this performance measure. However, this task is generally performed by an inpatient cardiovascular care team member, such as an inpatient CR team member or a hospital discharge planning team member.
PERFORMANCE MEASURE A-2 Cardiac Rehabilitation Patient Referral From an Outpatient Setting
All patients evaluated in an outpatient setting who within the past 12 months have experienced an acute MI, CABG surgery, a PCI, cardiac valve surgery, or cardiac transplantation, or who have CSA and have not already participated in an early outpatient CR program for the qualifying event/diagnosis are to be referred to such a program.
Numerator: Number of patients in an outpatient clinical practice who have had a qualifying event/diagnosis during the previous 12 months, who have been referred to an outpatient CR program.
(Note: The program may include a traditional CR program based on face-to-face interactions and training sessions or other options that include home-based approaches. If alternative CR approaches are used, they should be designed to meet appropriate safety standards.
A referral is defined as an official communication between the healthcare provider and the patient to recommend and carry out a referral order to an outpatient CR program. This includes the provision of all necessary information to the patient that will allow the patient to enroll in an outpatient CR program. This also includes a communication from the healthcare provider and/or healthcare system to the CR program that includes necessary information for the patient's referral information for the program. A hospital discharge summary or office note may potentially be formatted to include the necessary patient information to communicate to the CR program [the patient's cardiovascular history, testing, and treatments, for instance]. All communications must maintain an appropriate level of confidentiality as outlined by the 1996 Health Insurance Portability and Accountability Act [HIPAA].)
Exclusion Criteria:
❏ Patient-oriented barriers (patient refusal, for example) ❏ Provider-oriented criteria (patient deemed to have a high-risk condition or a contraindication to exercise, for example) performance measurement sets that involve disease states or other conditions for which CR services have been found to be appropriate and beneficial (eg, following MI, CABG surgery). This performance measure is provided in a format that is meant to allow easy and flexible inclusion into such performance measurement sets. Effective referral of appropriate inpatients to an outpatient CR program is the responsibility of the healthcare team within a healthcare system that is primarily responsible for providing cardiovascular care to the patient during the hospitalization.
Corresponding Guidelines and Clinical Recommendations
Class I (for the description of the class of recommendations and level of evidence used in this document, see Table 1 Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women 22 Class I: A comprehensive risk-reduction regimen, such as cardiovascular or stroke rehabilitation or a physician-guided home-or community-based exercise training program, should be recommended to women with a recent acute coronary syndrome or coronary intervention, new-onset or chronic angina, recent cerebrovascular event, peripheral arterial disease (level of evidence: A), or current/prior symptoms of heart failure and a left ventricular ejection fraction of less than 40% (level of evidence: B).
Challenges to Implementation
Identification of all eligible patients in an outpatient clinical practice will require that a timely, accurate, and effective system be in place. Communication of referral information by the outpatient clinical practice team to the outpatient CR program represents a potential challenge to the implementation of this performance measure.
Appendix B
Cardiac Rehabilitation/Secondary Prevention Performance Measurement Set B PERFORMANCE MEASURE B-1
Structure-Based Measurement Set
The CR program has policies in place to demonstrate that:
1.
A physician-director is responsible for the oversight of CR program policies and procedures and ensures that policies and procedures are consistent with evidencebased guidelines, safety standards, and regulatory standards. 43 This includes appropriate policies and procedures for the provision of alternative CR program services, such as home-based CR.
An emergency response team is immediately avail-
able to respond to medical emergencies. 44 i. In a hospital setting, physician supervision is presumed to be met when services are performed on hospital premises. 45 ii. In the setting of a freestanding outpatient CR program (owned/operated by a hospital, but not located on the main campus), a physician-directed emergency response team must be present and immediately available to respond to emergencies. iii. In the setting of a physician-directed clinic or practice, a physician-directed emergency response team must be present and immediately available to respond to emergencies. Numerator: The number of CR programs in the healthcare system that meet these structure-based performance measure criteria.
3.
❏ Healthcare system barriers (financial barriers or lack of CR programs near a patient's home, for example)
Denominator: Number of patients in an outpatient clinical practice who have had a qualifying event/ diagnosis during the previous 12 months and who do not meet any of the exclusion criteria mentioned in the "Numerator" section above.
Period of Assessment:
Twelve months following a qualifying event/diagnosis.
Method of Reporting:
Proportion of patients in an outpatient practice who have had a qualifying event/ diagnosis during the past 12 months and have been referred to a CR program.
Sources of Data:
Rationale
Cardiac rehabilitation services have been shown to help reduce morbidity and mortality in persons who have experienced a recent coronary artery disease event, but these services are used in less than 30% of eligible patients. 26 A key component for CR utilization is the appropriate and timely referral of patients to an outpatient CR program. While referral takes place generally when the patient is hospitalized for a qualifying event (MI, CSA, CABG surgery, PCI, cardiac valve surgery, or heart transplantation), there are many instances in which a patient can and should be referred from an outpatient clinical practice setting (eg, when a patient does not receive such a referral while in the hospital, or when the patient fails to follow through with the referral for whatever reason).
This performance measure has been developed to help healthcare systems implement effective steps in their systems of care that would optimize the appropriate referral of a patient to an outpatient CR program.
This measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve disease states or other conditions for which CR services have been found to be appropriate and beneficial (eg, following MI, CABG surgery). This performance measure is provided in a format that is meant to allow easy and flexible inclusion into such performance measurement sets.
Referral of appropriate outpatients to a CR program is the responsibility of the healthcare provider within a healthcare system that is providing the primary cardiovascular care to the patient in the outpatient setting.
www.jcrjournal.com AACVPR Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs 51 (no class of recommendation or level of evidence given)
All professional staff members have completed BLS training; at least 1 staff member is present who has successfully completed training in ACLS.
Medical supervision for moderate-to high-risk patients will be provided by a physician, registered nurse, or other appropriately trained staff member who has successfully completed AHA curriculum for ACLS and has met state and hospital or facility medico-legal requirements for defibrillation and other related practices. Exercise Standards for Testing and Training: A statement for health professionals from the American Heart Association. The AHA Scientific Statement 52 (no class of recommendation or level of evidence given)
An emergency response team is immediately available to respond to medical emergencies.
CMS National Coverage Determination for Cardiac Rehabilitation Programs 45 (no class of recommendation or level of evidence given)
Functional emergency resuscitation equipment and supplies for handling cardiovascular emergencies are immediately available in the exercise area.
Challenges to Implementation
Adherence to this measure requires the engagement of a physician-director who is accountable for policy development and implementation.
PERFORMANCE MEASURE B-2 Assessment of Risk for Adverse Cardiovascular Events
The CR program has the following processes in place:
1. Documentation, at program entry, that each patient undergoes an assessment of clinical status (eg, symptoms, medical history) in order to identify high-risk conditions for adverse cardiovascular events.
2.
A policy to provide recurrent assessments for each patient during the time of participation in the CR program in order to identify any changes in clinical status that increase the patient's risk of adverse cardiovascular events. If such findings are noted, the CR staff contacts the program's physician director and/or the patient's primary healthcare provider according to thresholds for communication included in the policies developed for Performance Measure B-3j.
Numerator: Number of CR programs in the healthcare system that meet the performance measure for assessment of risk for adverse cardiovascular events Denominator: Number of CR programs in the healthcare system
Period of Assessment: Per reporting year
Denominator: All CR programs within a healthcare system.
Method of Reporting: Inclusive data collection tracking sheet
Sources of Data: Written program policies
Rationale
The delivery of CR services is physician directed and provided by a multidisciplinary staff of healthcare professionals. A system for communication between a physician-director with expertise in CVD management and a referring or primary physician enhances the program's success in helping that patient achieve individualized target goals. It is the responsibility of the physician-director to assure that the information and instruction given to patients in CR is consistent with the most current clinical practice guidelines.
There is a growing trend among patients referred to and completing early outpatient CR to be older, at higher risk, and have more chronic comorbidities. 48 Medical supervision is the most important day-to-day safety factor in CR. 43 Personnel and equipment for ACLS are essential to the adequate delivery of emergency care for patients who experience cardiac arrest or other lifethreatening events during CR sessions.
Although rare, cardiovascular emergencies can occur during exercise training in CR programs. Studies suggest that the incidence of cardiac arrest requiring defibrillation is approximately 1 arrest every 100,000 patienthours. 49 Practice guidelines for management of cardiac arrest include the use of BLS and ACLS strategies, such as early defibrillation. Such strategies have been shown to help improve outcomes in persons who experience cardiac arrest. 50 Some CR programs seek certification of their program by healthcare organizations, such as the AACVPR, in order to show that they meet certain standards for the delivery of CR services. Such a certification process, while outside the scope of this document, may result in documentation of a program's ability to meet this (B-1) and other CR performance measures mentioned in this document. Currently, for instance, CR program certification through the AACVPR requires that all of the above policies (items 1 to 4 above) are in place and operational.
Corresponding Guidelines and Clinical Recommendations
Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs 43 (no class of recommendation or level of evidence given)
There is a physician-director responsible for program oversight and to ensure that policies and procedures are consistent with evidence-based guidelines, safety standards, and regulatory standards.
Exercise Standards for Testing and Training: A statement for healthcare professionals from the American Heart Association 52 (no class of recommendation or level of evidence given) Screening procedures can be used that identify an individual who is at risk for an exercise-related cardiac event, which may be helpful in reducing these occurrences.
After the medical evaluation is complete, subjects can be classified by risk on the basis of their characteristics. This classification is used to determine the need for subsequent supervision and the level of monitoring required.
PERFORMANCE MEASURE B-3 Individualized Assessment and Evaluation of Modifiable Cardiovascular Risk Factors, Development of Individualized Interventions, and Communication With Other HealthCare Providers
This performance measure includes 10 individual submeasures for the evaluation of modifiable cardiovascular risk factors, development of individualized interventions, and communication with other healthcare providers concerning these risk factors and interventions.
The rationale for including both recognition and intervention for satisfactory fulfillment of these measures is predicated upon the belief that high-quality cardiovascular care requires both the identification and treatment of known cardiovascular risk factors.
An important component of this performance measure is the expectation that the CR staff communicates with appropriate primary care providers and treating physicians in order to help coordinate risk factor management and to promote life-long adherence to lifestyle and pharmacological therapies. (See Performance Measure B-3j for more specific coverage of communication with the patient's primary healthcare provider.)
PERFORMANCE MEASURE B-3A: INDIVIDUALIZED ASSESSMENT OF TOBACCO USE
For each eligible patient enrolled in the CR program, there is documentation that the following criteria have been met:
1. An assessment is made of current and past tobacco use.
If current tobacco use is identified, an intervention plan is recommended to the patient and communicated to
Method of Reporting: Inclusive data collection tracking sheet
Sources of Data: Written program policies
Rationale
A standardized assessment should be performed to identify patients with unstable symptoms and other factors that place the patient at increased risk for adverse cardiovascular events. 17 When high-risk findings are noted, a patient should be considered for prompt evaluation and treatment, and rehabilitation recommendations should be adjusted accordingly.
Recurrent adverse cardiovascular events are relatively common in persons with CVD. In one study from Olmsted County, Minnesota, nearly half of patients discharged from the hospital following an MI had a recurrent adverse cardiovascular event in the 3 years following their MI. 53 However, adverse events are rare during CR early after a CVD event, occurring approximately once in every 100,000 patient-hours. 49 This safety record is likely due in part to standard procedures that exist in CR programs to frequently screen patients for signs and symptoms that increase their risk for adverse cardiovascular events. 17, 50 If a CR participant develops abnormal cardiovascular signs (significant arrhythmias or blood pressure abnormalities, for example) or symptoms (exertional chest pain, for instance), they typically receive prompt evaluation and care.
Published reports suggest limited accuracy of the risk stratification methods from the AACVPR, ACC/AHA, and the American College of Physicians in identifying patients at risk for adverse events during CR sessions. 54 However, one study found that a combination of the AACVPR criteria with a comorbidity index helped improve the accuracy of risk stratification, particularly among female patients. 55 A significant limitation to these studies is the fact that patients identified at high risk undergo additional evaluation and treatment to lower their risk, thereby dampening the ability of such screening measures to accurately identify individuals at increased risk of adverse cardiovascular events.
This performance measure does not cover the assessment of modifiable risk factors, such as blood pressure, cholesterol, and diabetes. Assessment of modifiable risk factors related to CVD progression and recurrent CVD events is covered in Performance Measure B-3. Percentage of patients queried 1 or more times during the reporting year about cigarette smoking.
Corresponding Guidelines and Clinical Recommendations
Percentage of patients identified as cigarette smokers who received smoking cessation intervention during the reporting year.
Challenges to Implementation
This measure relies on patient self-report.
PERFORMANCE MEASURE B-3B: INDIVIDUALIZED ASSESSMENT OF BLOOD PRESSURE CONTROL
1. An assessment is made of blood pressure (BP) control, with target goals defined by the AHA/ACC secondary prevention guidelines.
2.
For patients with a diagnosis of hypertension, an intervention plan is developed. This should include education about target BP goals, medication compliance, lifestyle modification for optimal dietary and physical activity habits, and weight control. 
Class I
Short-term Goal: Patient will demonstrate readiness to change by initially expressing decision to quit and selecting a quit date. Subsequently, patient will quit smoking and all tobacco use, adhere to pharmacological therapy (if prescribed), and practice relapse prevention strategies; patient will resume cessation plan as quickly as possible when temporary relapse occurs.
Long-term Goal:
Complete abstinence from smoking and use of all tobacco products for at least 12 months (maintenance) from quit date. been met:
1. An assessment of blood lipid control and use of lipidlowering medications, with target goals defined by the AHA/ACC secondary prevention guidelines.
2.
For patients with a diagnosis of hyperlipidemia, an intervention plan has been recommended to the patient. This should include education about target lipid goals, importance of medication compliance, lifestyle modification for optimal dietary and regular physical activity habits, and weight control. 
Rationale
Multiple clinical trials have shown the benefit of lipidlowering agents and lifestyle modification for patients with documented CVD. 39 A more aggressive low-density lipoprotein target goal of Ͻ70 mg/dL should be considered for persons with multiple cardiovascular risk factors, particularly when they are under suboptimal control (eg, a patient with coronary artery disease who continues to smoke). 
Corresponding Guidelines and Clinical Recommendations
Rationale
The BP levels represent a strong, consistent, continuous, independent, and etiologically relevant risk factor for cardiovascular and renal disease. Optimal control of BP has a beneficial impact on lowering cardiovascular risk. Treating systolic BP and diastolic BP to targets that are lower than 140/90 mm Hg is associated with a decrease in CVD complications. In patients with hypertension with diabetes or renal disease, the BP goal is lower than 130/80 mm Hg. 
39,57
Corresponding Guidelines and Clinical Recommendations
AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Related Performance Measurement Sets
Rationale
Adherence to regular physical activity has been associated with a 20% to 30% reduction in all-causes mortality in patients with CVD. Health professionals should prescribe physical activity programs commensurate with those recommended by the Centers for Disease Control and Prevention and the American College of Sports Medicine, that is, 30 minutes or more of moderate-intensity physical activity such as brisk walking on most, and preferably all, days of the week.
Challenges to Implementation
Community-based exercise may not utilize modalities designed for elderly patients and those with neurological and musculoskeletal disease, making continued regular physical activity a challenge for some patients.
PERFORMANCE MEASURE B-3E: INDIVIDUALIZED ASSESSMENT OF WEIGHT MANAGEMENT
For each eligible patient enrolled in the CR program, there is documentation that the following criteria have 2007 Update 57 (no class of recommendation or level of evidence given) Short-term Goal: Continued assessment and modification of intervention until the low-density lipoprotein level is lower than 100 mg/dL (further reduction to a goal (70 mg/dL is considered reasonable).
Long-term Goal: Low-density lipoprotein cholesterol level is lower than 100 mg/dL (further reduction to a goal Ͻ70 mg/dL is considered reasonable). Secondary Goal: Non-high-density lipoprotein cholesterol level is lower than 130 mg/dL (further reduction to a goal of Ͻ100 mg/dL is considered reasonable). Percentage of patients receiving at least 1 lipid profile during the reporting year. Percentage of patients who are receiving a statin (based on current ACC/AHA guidelines).
AHA
PERFORMANCE MEASURE B-3D: INDIVIDUALIZED ASSESSMENT OF PHYSICAL ACTIVITY HABITS
1. An assessment of current physical activity habits. 2. If physical activity habits at time of program entry do not meet suggested guidelines as defined by the AHA/ACC secondary prevention guidelines, then recommendations to improve physical activity habits are given to the patient.
3.
Prior to completion of the CR program, physical activity habits and the physical activity intervention plan are reassessed and communicated to the patient as well as to the primary care provider and/or cardiologist. Goals: Balance energy intake and physical activity to achieve and maintain a healthy body weight; consume a diet rich in vegetables and fruits; choose whole-grain, high-fiber foods; consume fish, especially oily fish, at least twice a week; limit intake of saturated fat to less than 7% of energy, trans fat to less than 1% of energy, and cholesterol to less than 300 mg/d by choosing lean meats and vegetable alternatives, fat-free (skim) or low-fat (1% fat) dairy products and minimize intake of partially hydrogenated fats; minimize intake of beverages and foods with added sugars; choose and prepare foods with little or no salt; if you consume alcohol, do so in moderation; and when you eat food prepared outside of the home, follow these diet and lifestyle recommendations.
Challenges to Implementation
Weight management relies on patient compliance with diet and lifestyle recommendations.
PERFORMANCE MEASURE B-3F: INDIVIDUALIZED ASSESSMENT OF THE DIAGNOSIS OF DIABETES MELLITUS OR IMPAIRED FASTING GLUCOSE
For each eligible patient enrolled in the CR program, there is documentation that the following criteria have been met: 
Rationale
Obesity is an independent risk factor for CVD and adversely affects CVD risk factors. By adhering to diet and lifestyle recommendations, patients can substantially reduce their risk of CVD. Educate patient and staff to be alert for signs/symptoms of hypoglycemia or hyperglycemia and provide appropriate assessment and interventions.
58
Corresponding Guidelines and Clinical Recommendations
Teach and practice self-monitoring skills for use during unsupervised exercise. Refer to registered dietitian for MNT. Consider referral to certified diabetic educator for skill training, medication instruction, and support groups.
Challenges to Implementation
Patients may not be aware that they have IFG or DM. In addition, it may be difficult for CR staff to obtain medical records to verify or refute the diagnosis. Given the latter, either patient self-report or medical records, if available, may be used to meet these criteria.
PERFORMANCE MEASURE B-3G: INDIVIDUALIZED ASSESSMENT OF THE PRESENCE OR ABSENCE OF DEPRESSION
1. Assessment of the presence or absence of depression, using a valid and reliable screening tool.
2.
If clinical depression is suspected as a result of screening, this has been discussed with the patient.
3.
If clinical depression is suspected as a result of screening, the primary care provider and/or mental healthcare provider have been notified. 
Rationale
The presence of DM or IFG has been linked to unfavorable long-term cardiovascular outcomes. Because improved glycemic control has been shown to favorably affect cardiovascular morbidity and mortality, 61 the CR program setting is an ideal environment to educate patients about the implications of DM or IFG and to initiate the behavior patterns that foster improved glycemic control.
56
Corresponding Guidelines and Clinical Recommendations
Physical Activity/Exercise and Type 2 Diabetes: A consensus statement from the American Diabetes Association 63 (no class of recommendation given)
Those who take insulin or secretagogues should check capillary blood glucose before, after, and several hours after completing a session of physical activity, at least until they know their usual glycemic responses to such activity (level of evidence: E, from the ADA classification system, in which level of evidence E is based on expert consensus or clinical experience).
American Diabetes Association Standards of Medical Care in Diabetes-2006 62 (no class of recommendation given)
Lowering HbA 1C has been associated with a reduction of microvascular and neuropathic complications of diabetes (level of evidence: A, from the ADA classification system, in which level A is based on clear evidence from wellconducted, generalizable, randomized controlled trials that are adequately powered).
People with DM should receive individualized medical nutrition therapy (MNT) as needed to achieve treatment goals, preferably provided by a registered dietitian familiar with the components of diabetes MNT (level of evidence: B, from the ADA classification system, in which level B is based on supportive evidence from well-conducted cohort studies).
Medicine and ACC/AHA practice guidelines and scientific statements.
52,70
2. An individualized exercise prescription, based on the assessment of exercise capacity, is recommended to the patient and communicated to the primary care provider and/or cardiologist.
3.
Prior to completion of the CR program, change in exercise capacity is reassessed and communicated to the patient as well as to the primary care provider and/or cardiologist.
Numerator: Number of patients in the healthcare system's CR program(s) who meet the performance measure for assessment of exercise capacity 
Rationale
Meta-analyses and systematic reviews have concluded that comprehensive, exercise-based CR reduces mortality rates in patients with CVD. 
Depression is highly prevalent among patients following acute cardiac events, with 20% to 45% of patients suffering significant levels of depressive symptoms after an acute MI. 64, 65 Depression has been shown to be a powerful, independent risk factor for cardiac mortality after an acute MI or unstable angina. 66, 67 Several studies suggest that depressed patients with CVD benefit from CR programs by improving coping skills and self-image, reducing biological risk factors such as social isolation and smoking, providing emotional support, and improving quality-of-life scores.
68
Corresponding Guidelines and Clinical Recommendations
Depression Screening in Cardiac Rehabilitation: AACVPR Task Force Report 69 (no class of recommendation or level of evidence given)
The AACVPR recommends that appropriately trained healthcare professionals in the CR setting assess for depression using a valid and reliable screening tool and ask specific questions about depression as a part of the intake assessment and/or clinical interview. They also recommend that cardiac rehabilitation professionals communicate findings indicating possible clinical depression to referring physicians, facilitate referral of patients for appropriate treatment, and periodically reassess therapeutic progress.
Challenges to Implementation
Depression screening includes patient self-report, but validated self-report tools are available to help facilitate screening for depression.
PERFORMANCE MEASURE B-3H: INDIVIDUALIZED ASSESSMENT OF EXERCISE CAPACITY
1. Assessment of maximal or submaximal exercise capacity, using at least 1 of several possible assessment methods that has standard end points as defined by groups such as the American College of Sports
Challenges to Implementation
In some cases, results of recent stress tests are available to assess exercise capacity, but this is not universal. The CR program may use an alternative assessment of exercise capacity, such as submaximal treadmill testing or a 6-minute walk.
PERFORMANCE MEASURE B-3I: INDIVIDUALIZED ADHERENCE TO PREVENTIVE MEDICATIONS
For each eligible patient with coronary artery disease enrolled in the CR program, there is documentation that the following criterion has been met:
The patient has received individual or group education concerning the importance of adherence to preventive medications that are described in the AHA/ACC secondary prevention guidelines. (Note: Patients should be encouraged to discuss questions or concerns about prescribed preventive medications with their healthcare providers.)
Numerator: Number of patients in the healthcare system's CR program(s) who meet the performance measure for adherence to preventive medications 
Rationale
The use of preventive medications that may or may not be tied to a specific risk factor (aspirin, omega-3 fatty acids, ␤-blockers, and angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker agents, for instance) are also critically important in reducing recurrent cardiovascular events in patients enrolled in a CR program. A gap in their usage is common, but can be corrected with the help of systematic programs, such as CR programs, that can promote the appropriate use of preventive medications and thereby improve patient outcomes. 
Sources of Data: Written program policies
Rationale
Continuous QI relies on collecting information about individual response to therapy as well as analysis of aggregate data to assess program effectiveness. The recommendation is that each CR program provides evidence of a standardized method to document individual patient outcomes on completion of the course of CR as defined on intake to the CR program which, in aggregate, will permit documentation of program effectiveness and QI initiative success.
Outcome assessment and evaluation provides evidence of effectiveness of therapeutic interventions. According to a recent report of the National Heart, Lung, and Blood Institute, this enhances the migration of best practice to clinical practice, improves decision making and the quality of care provided, and supports the optimal allocation of healthcare resources for all patients. 73 The 2004 AACVPR consensus statement document suggests that "no single form [or] assessment protocol… will fit the needs of all programs." 74 The document gives examples of outcome measures for evaluating program effectiveness and communicating with other healthcare professionals, providing the basis for a flexible "structural framework…that will guide programs in the development of standardized assessment protocols that fit their specific needs." 74 Initiation and completion of the prescribed course of CR, as defined on admission assessment, are keys to promoting both life-long behavior change as well as physiologic adaptations from regular exercise. Comprehensive CR programs include core components designed to address secondary prevention issues that can improve with patient self-management. Reassessment of outcome measures after completion of CR can help programs assess their performance in each of these core components. It is anticipated that programs would assess different core components outcomes over time, using aggregate results to assess issues such as overall program performance, alternative approaches to programming, and programming in underserved populations such as minorities, women, and the elderly. It is essential to the success of any program that each of these interventions is performed in concert with the patient's primary care provider and/or cardiologist, who will subsequently supervise and refine these interventions over the long term.
Corresponding Guidelines and Clinical Recommendations
Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondary Prevention Programs 43 (no class of recommendation or level of evidence given) By working closely with referring physicians, the cardiac rehabilitation team can assist the patient in reaching target goals more effectively.
Challenges to Implementation
CR programs may not have access to all data related to risk factor control, such as most recent lipid profile, HbA 1C , or patient-specific contraindications to preventive medications.
PERFORMANCE MEASURE B-4 Monitor Response to Therapy and Document Program Effectiveness
For each CR program in a healthcare system, a written policy is in place to:
1. Document the percentage of patients for whom the CR program has received a formal referral request who actually enroll in the program.
2. Document for each patient a standardized plan to assess completion of the prescribed course of CR as defined on entrance to the program.
3. Document for each patient a standardized plan to assess outcome measurements at the initiation and again at the completion of CR, including at least 1 outcome measure for the core program components as outlined in the Cardiac Rehabilitation/Secondary Prevention Performance Measure Set B, Performance Measure 3.
4.
Describe the program's methodology to document program effectiveness and initiate QI strategies.
Numerator: Number of CR programs in the healthcare system that meet this performance measure for monitoring response to therapy and documenting program effectiveness The assessment and evaluation of at least 1 of the expected outcome measures is recommended for each of the core cardiac rehabilitation components. 
